MedTrace Logo

Brachial Plexus Block vs General Anesthesia in Upper Extremity Surgery

NCT07352839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-01-20

No results posted yet for this study

Summary

This study compares two different anesthesia methods for upper arm and hand surgery: regional anesthesia (brachial plexus block) versus general anesthesia.

Regional anesthesia numbs only the arm being operated on by injecting local anesthetic near the nerves, while the patient remains awake or lightly sedated. General anesthesia puts the patient completely asleep using medications given through a breathing tube.

The main goals of this study are to compare:

* How much pain patients experience after surgery
* Patient satisfaction with their anesthesia
* Side effects such as nausea, vomiting, or breathing problems
* Time until patients are ready to go home
* Overall safety of each method

Participants in this study will be randomly assigned to receive either brachial plexus block or general anesthesia for their scheduled upper extremity surgery. The research team will monitor participants during surgery and follow their recovery for 24 hours after the operation.

This research will help doctors and patients make better-informed decisions about which type of anesthesia may be best for upper extremity procedures.

Conditions

  • Upper Extremity Surgery
  • Regional Anesthesia
  • General Anesthetic

Interventions

PROCEDURE

Brachial Plexus Block

Ultrasound-guided infraclavicular brachial plexus block using local anesthetic (e.g., ropivacaine or bupivacaine). Block performed before surgery to provide regional anesthesia for upper extremity surgery.

PROCEDURE

General Anesthesia

Standard general anesthesia with intravenous induction and maintenance with volatile anesthetics or total intravenous anesthesia (TIVA). Endotracheal intubation or laryngeal mask airway used as appropriate.

Sponsors & Collaborators

  • Adana City Training and Research Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-09
Primary Completion
2025-11-03
Completion
2025-11-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07352839 on ClinicalTrials.gov